Symbol | Exchange | Currency |
|---|
March 18 (Reuters) - Auscann Group Holdings Ltd AC8.AX : * CANNPAL ANIMAL THERAPEUTIC IMPLEMENTED SCHEME UNDER WHICH CANNPAL SHAREHOLDERS GOT 1.3 SHARES IN CO FOR EVERY 1 SHARE...
Feb 22 (Reuters) - Auscann Group Holdings Ltd AC8.AX : * CHARLES ALTSHULER WILL BE APPOINTED CHIEF FINANCIAL OFFICER
Jan 8 (Reuters) - Auscann Group Holdings Ltd AC8.AX : * AUSCANN LEADERSHIP POST CANNPAL ACQUISITION,CP1-AC8.AX * NICK WOOLF HAS DECIDED TO TENDER HIS RESIGNATION AS CEO * NICK...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
AusCann Group Holdings Limited is an Australia-based company, which is focused on the development and commercialization of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Neuvis is its controlled-dose technology platform, which delivers cannabinoids (CBD) to human patients, with the first product in the range being a THC:CBD hard-shell capsule in a 1:1 ratio, in both a 2.5mg and 10mg strength. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol and cannabidiol whole plant extracts in a ratio to target pain and inflammation in dogs. DermaCann is its CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. MicroMAX is an encapsulation technology, which helps to enhance the delivery of cannabis-based animal health products. Its subsidiaries include AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | |||||
| Technical Indicators | |||||
| Summary |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 22.49 | 23.25 | 22.36 | +0.010 | +0.04% | 7.14M | Sydney | |||
| 6.49 | 6.53 | 6.46 | +0.02 | +0.31% | 5.71M | Sydney | |||
| 36.42 | 37.70 | 36.42 | -0.890 | -2.39% | 5.36M | Sydney | |||
| 109.85 | 109.95 | 108.95 | +1.020 | +0.94% | 2.19M | Sydney | |||
| 2.56 | 2.63 | 2.56 | -0.02 | -0.78% | 386.84K | Sydney | |||
| 49.00 | 49.38 | 48.85 | -0.31 | -0.63% | 579.09K | Sydney | |||
| 35.15 | 35.28 | 34.84 | +0.410 | +1.18% | 1.57M | Sydney | |||
| 23.93 | 23.97 | 23.76 | +0.260 | +1.10% | 4.70M | Sydney | |||
| 0.655 | 0.67 | 0.65 | 0.00 | 0.00% | 6.37M | Sydney | |||
| 0.021 | 0.022 | 0.02 | -0.001 | -4.55% | 5.50M | Sydney | |||
| 5.84 | 6.29 | 5.80 | -0.580 | -9.03% | 14.51M | Sydney | |||
| 126.97 | 128.05 | 126.50 | +0.470 | +0.37% | 1.25M | Sydney | |||
| 0.022 | 0.022 | 0.022 | 0.00 | 0.00% | 420.58K | Sydney | |||
| 1.615 | 1.645 | 1.612 | -0.020 | -1.22% | 11.97M | Sydney | |||
| 1.95 | 1.95 | 1.945 | 0.00 | 0.00% | 0.00 | Sydney |